Human-level artificial intelligence (AI), popularly referred to as Artificial General Intelligence (AGI) could arrive by as ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Google’s DeepMind is reportedly holding back from publishing AI research papers over fears of losing its competitive edge.
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Demis Hassabis was a child chess prodigy, achieving master status in his teens. In a lecture at the University of Cambridge, the Google Deepmind CEO said chess led him to his first experience with AI.
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, knows this firsthand. In 2016, after AlphaGo—the AI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results